SlideShare une entreprise Scribd logo
1  sur  104
IASO Quiz 2013
Instituted by
Dr Panda and Dr K Gopinath
Identify this cancer survivor
Identify this cancer survivor

Lance Armstrong
Following the 2012 USPSTF
recommendation against PSA screening in
all men, which group saw a decrease in
screening frequency by PCPs?
A. Men between 40-49yrs
B. Men above 79 yrs
C. Patients with previous highest PSA
<2.49ng/ml
D. All the above
Following the 2012 USPSTF
recommendation against PSA screening in
all men, which group saw a decrease in
screening frequency by PCPs?
A. Men between 40-49yrs
B. Men above 79 yrs
C. Patients with previous highest PSA
<2.49ng/ml
D. All the above
Cohn JA, et al. Urol Oncol. 2013 Aug 1. [Epub ahead of print]
PSA screening is likely to reduce mortality
due to prostate cancer. However the
conclusion is likely to be affected by
A.
B.
C.
D.

Selection Bias
Lead and length Bias
Exposure and measurement issues
All the above
PSA screening is likely to reduce mortality
due to prostate cancer. However the
conclusion is likely to be affected by
A.
B.
C.
D.

Selection Bias
Lead and length Bias
Exposure and measurement issues
All the above
Urethral Cancer which invades bladder
neck, single inguinal node 3cm is
staged
A.
B.
C.
D.

T4N2M0
T4N1M0
T2N1M0
T3N2M0
Urethral Cancer which invades bladder
neck, single inguinal node 3cm is
staged
A.
B.
C.
D.

T4N2M0
T4N1M0
T2N1M0
T3N2M0
Micromets play an important role in the
natural progression of urothelial cancer.
What percentage of organ confined node
negative bladder cancers recur following
cystectomy?
A.
B.
C.
D.

25%
5%
40%
60%
Micromets play an important role in the
natural progression of urothelial cancer.
What percentage of organ confined node
negative bladder cancers recur following
cystectomy?
A.
B.
C.
D.

25%
5%
40%
60%

Bladder cancer: Diagnosis Therapeutics and Management.
Ed.Cheryl T Lee and David P Wood. 2010 page 89.
BCG for superficial bladder cancer can
be potentiated for additional benefit if
combined with which of the following:
A.
B.
C.
D.

Mitomycin C
Interferon
Epirubicin
None of the above
BCG for superficial bladder cancer can
be potentiated for additional benefit if
combined with which of the following:
A.
B.
C.
D.

Mitomycin C
Interferon
Epirubicin
None of the above

Zhu S et al. BMC cancer 2013,Jul 5; 13: 322. Pooled results of a recent
meta-analysis of 21 RCT and 9 comparative studiess showed a
better recurrence free survival for BCG+Epirubicin at the cost of an
increase in toxicity.
Intravesical BCG for non muscle
invasive bladder cancer for older
patients
A.
B.
C.
D.

Improves Overall Survival
Improves Bladder cancer specific survival
Improves Os but not BCSS
Improves OS and BCSS
Intravesical BCG for non muscle
invasive bladder cancer for older
patients
A.
B.
C.
D.

Improves Overall Survival
Improves Bladder cancer specific survival
Improves Os but not BCSS
Improves OS and BCSS

Spencer BA, et al. J Oncol Pract. 2013;9(2):92-98.
Name the medicinal Plant/tree/seeds

Supposed to enhance memory
Name the medicinal Plant/tree/seeds

Supposed to enhance memory
Ginko biloba
The correct statement below is:
A. HPV vaccination is highly effective against
development of cervical dysplasia
B. HPV vaccination is highly effective against
development of anal and cervical dysplasia
C. HPV vaccination is highly effective against
development of cervical, anal and oral
dysplasia
The correct statement below is:
A. HPV vaccination is highly effective against
development of cervical dysplasia
B. HPV vaccination is highly effective against
development of anal and cervical dysplasia
C. HPV vaccination is highly effective against
development of cervical, anal and oral
dysplasia
Palefsky et al. NEJM 2011;365(17):1576
Vit D receptor Bsm1 polymorphism may
represent a risk factor for _______ women
with ovarian cancer
A.
B.
C.
D.

Asian
North American
European
South American
Vit D receptor Bsm1 polymorphism may
represent a risk factor for _______ women
with ovarian cancer
A.
B.
C.
D.

Asian
North American
European
South American

VDR Bsm1 polymorphism is generally no associated with Ovarian
cancer risk. However a subgroup analysis of the study by Qin
X et al ( Int J Gyn Cancer 2013. 23(7): 1178-83) showed
european population to be at risk.
Which is not a paraneoplastic
syndrome associated with Lung Cancer
A.
B.
C.
D.

Horner’ syndrome
Lambert-Eaton Syndrome
Sweet’s Syndrome
Dermatomyositis
Which is not a paraneoplastic
syndrome associated with Lung Cancer
A.
B.
C.
D.

Horner’ syndrome
Lambert-Eaton Syndrome
Sweet’s Syndrome
Dermatomyositis
The syndrome was first described in 1964 by Dr. Robert D
Sweet. It was also known as Gomm-Button disease in
honour of the first two patients diagnosed. It is
characterized by erythematous well defined cutaneous
papules associates with fever and is associated with
haematologic malignancies like leukaemia, Rheumatoid
Arthritis, IBD, Behcets Syndrome.
The dividing line to discriminate 2R
and 4R from 2L and 4L when staging
Lung Cancer is
A. Midline of trachea
B. Right Border of Trachea
C. Left border of Trachea
The dividing line to discriminate 2R
and 4R from 2L and 4L when staging
Lung Cancer is
A. Midline of trachea
B. Right Border of Trachea
C. Left border of Trachea
Nodal station not amenable to be assessed
by standard cervical mediastinoscopy for
staging lung cancer
A.
B.
C.
D.

Station 3
Station 6
Station 7
Station 5
Nodal station not amenable to be assessed
by standard cervical mediastinoscopy for
staging lung cancer
A.
B.
C.
D.

Station 3
Station 6
Station 7
Station 5
This 62 yr old pathologist who has
undergone complete resection for a lung
cancer is staged pT2 N0 M0. He asks you
regarding adjuvant therapy with Geftinib.
Your answer is-A. Yes it is beneficial in stage Ib, II and IIIa lung
cancer
B. Adjuvant Geftinib benefits only wild type EGFR
C. Adjuvant Geftinib benefits only mutant EGFR
D. No benefit of Adjuvant Geftinib
This 62 yr old pathologist who has
undergone complete resection for a lung
cancer is staged pT2 N0 M0. He asks you
regarding adjuvant therapy with Geftinib.
Your answer is-A. Yes it is beneficial in stage Ib, II and IIIa lung
cancer
B. Adjuvant Geftinib benefits only wild type EGFR
C. Adjuvant Geftinib benefits only mutant EGFR
D. No benefit of Adjuvant Geftinib
Gross GD et al. JCO 2013; 31(17) 3320-26. Trial was stopped mid way due
to lack of benefit
Not associated with pleural
Mesothelioma
A.
B.
C.
D.

SV 40 infection
Erionite exposure
Thorium Dioxide therapy
HPV Infection
Not associated with pleural
Mesothelioma
A.
B.
C.
D.

SV 40 infection
Erionite exposure
Thorium Dioxide therapy
HPV Infection
Lung Cancer : Prevention, Management and Emerging Therapies. David J
Stewart Ed. 2010; page 437.
OCP and HRT use are associated with
increase in breast cancer and Lung
cancer
A. True
B. False
OCP and HRT use are associated with
increase in breast cancer and Lung
cancer
A. True
B. False
ILCC pooled analysis of 6 case control studies ( 1961 cases
and 2609 controls) found a reduced risk of lung ca in HRT
(Adeno and Small Cell) and OCP (Squamous CA)users. There
was no dose response relationship with years of OCP/HRT.
Pesatori AC et al. Br J Cancer 2013; 109(7) 1954-64.
Which of the following is an inhibitor
of PDGFR
A.
B.
C.
D.

Dasatinib
Vandetanib
Sorafenib
Imatinib
Which of the following is an inhibitor
of PDGFR
A.
B.
C.
D.

Dasatinib
Vandetanib Sorafenib
Imatinib
-

VEGFR-2
DS DNA break repair
Bcl-2
Name the book by this Ethiopia born
physician which talks of liver
transplantation
A. My Journey
B. Another life
C. Cutting for Stone
D.Emperor’s Malady
Name the book by this Ethiopia born
physician which talks of liver
transplantation
A. My Journey
B. Another life
C. Cutting for Stone
D.Emperor’s Malady
Does higher UV radiation exposure of
pregnant women reduce incidence of
some childhood cancers
A. Yes

B. No
Does higher UV radiation exposure of
pregnant women reduce incidence of
some childhood cancers
A. Yes
•

•

B. No

Lombardi C et al. cancer Epidemiology, Biomarkers and Prevention
2013;22(6): 1118-1128
Results: For cases with UVR exposure of 5,111 Watt-hours/m2 or above, we
estimated a reduction in odds of developing acute lymphoblastic leukemia
(OR: 0.89, 95% CI: 0.81–0.99), hepatoblastoma (OR: 0.69, 95% CI: 0.48–1.00),
and non-Hodgkin's lymphoma (OR: 0.71, 95% CI: 0.50–1.02) adjusting for
mother's age, mother's race, and child's year of birth. We also observed a
small increase in odds for intracranial/intraspinal embryonal tumors (OR: 1.29,
95% CI: 1.01–1.65).
Conclusions: Our findings suggest that UVR during pregnancy may decrease
the odds of some childhood cancers. Future studies should explore additional
factors that may be correlated with UVR exposure and possibly include
biomarkers of immune function and vitamin D.
Melanoma subtype which is
characterized by bland fibroblastic
appearance and often mimics a scarA.
B.
C.
D.

Desmoplastic
Acral Letigenous
Nodular
Lentigo maligna
Melanoma subtype which is
characterized by bland fibroblastic
appearance and often mimics a scarA.
B.
C.
D.

Desmoplastic
Acral Letigenous
Nodular
Lentigo maligna
DM are strongly and homogeneously positive for S-100 protein but are often

negative or only focally positive for melanocyte differentiation antigens such
as tyrosinase, gp100, Melan-A, and microphthalmia transcription factor. DM
differs from conventional melanoma in its clinical course. It is associated
with a higher tendency for local recurrence, but metastases to regional
lymph nodes are less common.
Wood BA. Pathology 2013; 45(5): 453-463
Who is this medical inventor
A. Dr Eric Blom.
B. Dr Robert Esther
C. Dr Douglas J. Schwartzentruber
Who is this medical inventor
A. Dr Eric Blom. Inventor of
the Blom Singer Prosthesis
for laryngectomee patients
B. Dr Robert Esther
C. Dr Douglas J. Schwartzentruber
Melanoma Vaccine
Pet scan is often advised for follow-up
in patients treated for HNSCC. Which
of the following is correct statement
A. PET scan does not obviate the need for
standard radiology
B. Two negative PET scans at 6 month intervals
obviates the need for additional radiology
C. Single negative PET scan obviates the need
for additional radiology
Pet scan is often advised for follow-up
in patients treated for HNSCC. Which
of the following is correct statement
A. PET scan does not obviate the need for
standard radiology
B. Two negative PET scans at 6 month intervals
obviates the need for additional radiology
C. Single negative PET scan obviates the need for
additional radiology
Mc Dermott et al. AJNR 2013; 34(8): 1631-36
The NPV of 2 negative PET scans at 6 month intervals was 98% compared
to 91% for a single negative PET scan
Most likely site of an asymptomatic
recurrence of H&N cancer is
A.
B.
C.
D.

Thoracic
Abdominal
Regional nodal
Primary site
Most likely site of an asymptomatic
recurrence of H&N cancer is
A.
B.
C.
D.

Thoracic
Abdominal
Regional nodal
Primary site

Dunsky KA et al. Laryngoscope 2013; 123(9): 2161-64
H&N Liposarcomas are likely to be
A. Commonly deep and have poor outcome
B. DFS and OS poorer than conventional
liposarcoms
C. Low grade and early stage
D. Deep seated but low grade and stage
H&N Liposarcomas are likely to be
A. Commonly deep and have poor outcome
B. DFS and OS poorer than conventional
liposarcoms
C. Low grade and early stage
D. Deep seated but low grade and stage
Gerry D et al. Head and Neck 2013; Jun 01 Epub
Stage IVa H&N Melanoma is
A.
B.
C.
D.

T1 N2 M0
T3 N1 M0
T4b N0 M0
T3 N2 M0
Stage IVa H&N Melanoma is
A.
B.
C.
D.

T1 N2 M0
T3 N1 M0
T4b N0 M0
T3 N2 M0
One of the following is not implicated
in the development of carcinoma of
the larynx.
A.
B.
C.
D.

Tobacco
Leather Dust
Strong Inorganic Mists
Asbestos Dust and Fibre
.
One of the following is not implicated
in the development of carcinoma of
the larynx.
A.
B.
C.
D.

Tobacco
Leather Dust
Strong Inorganic Mists
Asbestos Dust and Fibre
Head and Neck CA. Current Perspectives and Challenges. Ed James A
Radosevich. 2013: page 58. The other 3 have a strong association. Others
with limited evidence are HPV 16,18, Sulfur Mustard, Rubber production,
secondary tobacco smoke. Less than 1% are due to alcohol alone.
The journey of this physician’s
discovery and clinical application was
captured in a Hollywood movie in
2008 starring Harry Connick A. Living Proof
B. A Gift of Life
C. Nude Rats
D.The Lonely Road
The journey of this physician’s
discovery and clinical application was
captured in a Hollywood movie in
2008 starring Harry Connick A. Living Proof
B. A Gift of Life
C. Nude Rats
D.The Lonely Road
Triple negative breast cancers typically
demonstrate
A.
B.
C.
D.

Chemotherapy sensitivity
Chemotherapy insensitivity
Sensitive to only cisplatin
Chemotherapy sensitivity followed shorter
durable response
Triple negative breast cancers typically
demonstrate
A.
B.
C.
D.

Chemotherapy sensitivity
Chemotherapy insensitivity
Sensitive to only cisplatin
Chemotherapy sensitivity followed shorter
durable response
The residual tumour excised at surgery
following neoadjuvant therapy with
Trastuzumab and Chemotherapy is
likely to have -A.
B.
C.
D.

Retained Her2 expression
Gained Her2 point mutations
Lost Her2 expression
Lost Her2 point mutations
The residual tumour excised at surgery
following neoadjuvant therapy with
Trastuzumab and Chemotherapy is
likely to have -A.
B.
C.
D.
•

Retained Her2 expression
Gained Her2 point mutations
Lost Her2 expression
Lost Her2 point mutations
In a study of 167 HER2-positive breast cancer patients, participants who received
neoadjuvant chemotherapy without anti-HER2 treatment were more likely to demonstrate
HER2 loss within their residual disease (40% vs 14.7%, P=0.019). Additionally, HER2 loss
demonstrated a trend towards higher risk of relapse (HR 2.41, P=0.063). The pCR is
confirmed as a powerful predictor of long-term outcome. The rate of HER2 loss is higher in
patients receiving neoadjuvant CT without anti-HER2 agents. HER2 status on residual disease
after preoperative therapy can be helpful in selecting patients at different risk of relapse, to
be included in prospective trial exploring further adjuvant therapy.
Guarneri V, et al. Ann Oncol. 2013 Sep 7. [Epub ahead of print]
Which of the following predicts the
possibility of recurrence in node
negative breast cancer
A.
B.
C.
D.

Lymphovascular invasion
Age of patient
Perineural spread
Adjuvant radiotherapy
Which of the following predicts the
possibility of recurrence in node
negative breast cancer
A.
B.
C.
D.

Lymphovascular invasion
Age of patient
Perineural spread
Adjuvant radiotherapy
In a study of 716 patients with node-negative breast cancer, 47
ultimately recurred during 47 months of median follow-up.
Lymphovascular invasion (HR 4.6) and Nottingham grade 3 (HR 4.99)
tumors were independent risk factors associated with an increased risk
of recurrence. Adjuvant radiotherapy (HR 0.35) decreased tumor
recurrence, while adjuvant chemotherapy had no effect.
Lin PH. J Surg Oncol 2013; 108(6): 352
Your 52 yr old patient treated for HR+ EBC
and now on Exemestrane says she is in the
pink of health with no musculoskeletal
symptoms, vasomotor or vulvovaginal
symptoms. Inference on her survival-A. She likely to have a decreased survival
B. No inference can be drawn
C. She has same survival as for her stage of
cancer
D. She is likely to have a better survival
Your 52 yr old patient treated for HR+ EBC
and now on Exemestrane says she is in the
pink of health with no musculoskeletal
symptoms, vasomotor or vulvovaginal
symptoms. Inference on her survival-A.
B.
C.
D.

She likely to have a decreased survival
No inference can be drawn
She has same survival as for her stage of cancer
She is likely to have a better survival
Fontein DB et al. JCO 2013; 31(18): 2257-64
International Tamoxifen Exemestrane Multinational Trial
The drugs recommended for breast
cancer risk reduction in a 50yr old
postmenopausal lady with family
history of breast cancer and dense
breasts are
A. Raloxifene or Tamoxifen
B. Raloxifene only
C. Raloxifene, Tamoxifen and Exemestrane
The drugs recommended for breast
cancer risk reduction in a 50yr old
postmenopausal lady with family
history of breast cancer and dense
breasts are
A. Raloxifene or Tamoxifen
B. Raloxifene only
C. Raloxifene, Tamoxifen and Exemestrane
Moyer VA, et al. Ann Intern Med. 2013 Sep 24. USPSTF recommendations
Attachment of H Pylori to the gastric
epithelium leads to activation of NF-Kb
and increased
A. IL-8
B. VEGF
C. MMP-2
D. HGF
Attachment of H Pylori to the gastric
epithelium leads to activation of NF-Kb
and increased
A. IL-8
B. VEGF
C. MMP-2
D. HGF
Use of S-1 a novel drug based on 5FU with
Cisplatin compared to the standard
Cisplatin + 5FU for gastric cancer reveals
A. Cis plat + S-1 is more effective
B. Increased incidence of Stomatitis, Febrile
neutropenia
C. Lower incidence of hand foot syndrome
D. Increased treatment related deaths
Use of S-1 a novel drug based on 5FU with
Cisplatin compared to the standard
Cisplatin + 5FU for gastric cancer reveals
A. Cis plat + S-1 is more effective
B. Increased incidence of Stomatitis, Febrile
neutropenia
C. Lower incidence of hand foot syndrome
D. Increased treatment related deaths
Ajani JA et al. Eur J Cancer 2013; 49(17):3616-24. CS is
noninferior to CF and has improved safety
What is not true for follow up of
Stage II and III Colon Cancer
A. 80% recurrences occur in the first 2-2.5 yrs
B. CT abdomen and chest recommended
annually for 3 yrs
C. If surveillance colonoscopy is fine at 1 yr
colonoscopy is done every 2 yrs
D. PET scan can be recommended as part of a
trial only
What is not true for follow up of
Stage II and III Colon Cancer
A. 80% recurrences occur in the first 2-2.5 yrs
B. CT abdomen and chest recommended
annually for 3 yrs
C. If surveillance colonoscopy is fine at 1 yr
colonoscopy is done every 2 yrs
D. PET scan can be recommended as part of a
trial only
ASCO endorsed the guideline prepared by CCO ( JCO Nov 2012 )
Incorrect about carcinoid tumours
A. Causes depletion of tyrosine
B. Some patients may have dermatological
manifestations in sun exposed parts
C. 10% secrete excessive levels of Serotonin
D. May produce tricuspid stenosis
Incorrect about carcinoid tumours
A. Causes depletion of tyrosine. The aminoacid
depleted is tryptophan
B. Some patients may have dermatological
manifestations in sun exposed parts
C. 10% secrete excessive levels of Serotonin
D. May produce tricuspid stenosis
This computer scientist and professor at
Carnagie Mellon University was an author
of a best seller called
A. Alice project
B. Time management
C. Achieving your
childhood dreams
D.The last lecture
This computer scientist and professor at
Carnagie Mellon University was an author
of a best seller called
A. Alice project
B. Time management
C. Achieving your
childhood dreams
D.The last lecture by
Randy Pausch
The 5 year survival of stage 1
pancreatic cancer is-A.
B.
C.
D.

Less than 30%
50%
65%
5%
The 5 year survival of stage 1
pancreatic cancer is-A.
B.
C.
D.

Less than 30%
50%
65%
5%
In patients with nonfunctioning pancreatic
neuroendocrine tumors (NF-PanNETs), when
preoperative grading assessment is not
achieved, which clinical variable is an excellent
predictor of post-treatment nodal positivity?
A.
B.
C.
D.

Radiological tumour size
BMI
Age
Gender
In patients with nonfunctioning pancreatic
neuroendocrine tumors (NF-PanNETs), when
preoperative grading assessment is not
achieved, which clinical variable is an excellent
predictor of post-treatment nodal positivity?
A.
B.
C.
D.

Radiological tumour size
BMI
Age
Gender
Partelli S, et al. JAMA Surg. 2013;148(10):932-939.
In patients with hepatocellular carcinoma
(HCC) receiving transarterial therapy
(TACE/TAE), which is NOT a prognostic
factor for risk of death?
A.
B.
C.
D.

Albumin > 3.6 g/dl
Bilirubin > 17umol/l
Tumour Size > 7 cm
AFP >400ng/dl
In patients with hepatocellular carcinoma
(HCC) receiving transarterial therapy
(TACE/TAE), which is NOT a prognostic
factor for risk of death?
A.
B.
C.
D.

Albumin > 3.6 g/dl
Bilirubin > 17umol/l
Tumour Size > 7 cm
AFP >400ng/dl
This is the hepatoma arterial embolization prognostic score.
Kadalayil L, et al. Ann Oncol. 2013;24(10):2565-2570.
For adult survivors of childhood cancer,
which organ system is the most at-risk for
disease during adulthood after exposure to
treatment with potential toxicity?
A.
B.
C.
D.

Pulmonary
Haematopoietic
Hepatic
Gastrointestinal
.
For adult survivors of childhood cancer,
which organ system is the most at-risk for
disease during adulthood after exposure to
treatment with potential toxicity?
A.
B.
C.
D.

Pulmonary
Haematopoietic
Hepatic
Gastrointestinal
Less than 15% develop haematopoietic, hepatic, skeletal
dysfunction. Other organs at risk are cardiac, neurologic,
neurocognitive and endocrine.
Hudson MM, et al. JAMA. 2013;309(22):2371-2381.
What percentage of adult survivors of
childhood cancer develop an adult
neoplasm (benign and or malignant)
A.
B.
C.
D.

16%
45%
3%
0.5%
What percentage of adult survivors of
childhood cancer develop an adult
neoplasm (benign and or malignant)
A.
B.
C.
D.

16%
45%
3%
0.5%

Hudson MM, et al. JAMA. 2013;309(22):2371-2381.
This actor was diagnosed with ---- in
the film
A. Leukaemia
B. Brain Tumour
C. Lymphosarcoma
of Intestine
Risk of recurrence in GIST after surgery
is high (55% or more)in all except:
A.
B.
C.
D.

More than 10 cm size in any location
2-5cm with mitosis 5 per 50HPF
Mucosal invasion
Mitosis >1 per 5HPF
Risk of recurrence in GIST after surgery
is high (55% or more)in all except:
A.
B.
C.
D.

More than 10 cm size in any location
2-5cm with mitosis 5 per 50HPF
Mucosal invasion
Mitosis >1 per 5HPF
Most of the GIST are positive for CD117.
Approximately 8% are CD117 negative but
PDGFRA positive. These tumours areA. Clinically indolent, located in small intestine
B. Clinically aggressive, located in stomach and
C. Clinically indolent, located in stomach,
Most of the GIST are positive for CD117.
Approximately 8% are CD117 negative but
PDGFRA positive. These tumours areA. Clinically indolent, located in small intestine
B. Clinically aggressive, located in stomach and
C. Clinically indolent, located in stomach
Haematology Oncology Clinics: Rare Cancers. Dec 2012.
These PDGFRA positive tumours commonly are of epithelioid
morphology and the commonest mutation is on exon 18 (D842V) which
makes them resistant to TKI
The expected DFS following non
operative management of clinical CR
of Stage I-III rectal cancer treated by
neoadjuvant CCRT is
A.
B.
C.
D.

50%
80%
60%
40%
The expected DFS following non
operative management of clinical CR
of Stage I-III rectal cancer treated by
neoadjuvant CCRT is
A.
B.
C.
D.

50%
80%
60%
40%

Solanki AA et al. Onco Targets and therapy 2013; 2013(6): 1097-1110
Who is this surgeon
A.Frank H. Netter
B.B Fisher
C.CW Lilliehei
Who is this surgeon
A. Frank H. Netter was an American
surgeon and celebrated medical
illustrator. The first edition of his
Atlas of Human Anatomy — his
"personal Sistine Chapel" — was
published in 1989 and he was made
a Fellow of the New York Academy
of Medicine
B. B Fisher
C. CW Lilliehei
Statistics: the incorrect statement is
A. Type 1 error is fixed apriori
B. Increasing sample size has no effect on type 2
error
C. Doubling sample size does not affect
confidence interval
D. Sample size and effect size are inversely
related
Statistics: the incorrect statement is
A. Type 1 error is fixed apriori
B. Increasing sample size has no effect on type
2 error
C. Doubling sample size does not affect
confidence interval
D. Sample size and effect size are inversely
related
Which is not a subtypes of Chondroma
A.
B.
C.
D.

Ectochondroma
Enchondroma
Perosteal chondroma
Soft tissue Chondroma
Which is not a subtypes of Chondroma
A.
B.
C.
D.

Ectochondroma
Enchondroma
Perosteal chondroma
Soft tissue Chondroma
What minimum dose of radiation is
needed to produce a statistically
superior response to bone pain
A.
B.
C.
D.

10 Gy
8 Gy
15 Gy
4 Gy
What minimum dose of radiation is
needed to produce a statistically
superior response to bone pain
A.
B.
C.
D.

10 Gy
8 Gy
15 Gy
4 Gy
Dennis K. Radiother Oncol 2013; 106(1) 5-14
In this systematic analysis the authors found that the minimum dose of
8Gy was needed to reduce pain in bone mets.
Most common Uterine Sarcoma
A.
B.
C.
D.

Carcinosarcoma
Endometrial stromal sarcoma
Leiomyosarcoma
Adenosarcoma
Most common Uterine Sarcoma
A.
B.
C.
D.

Carcinosarcoma
Endometrial stromal sarcoma
Leiomyosarcoma
Adenosarcoma
He hypothesised the angiogenesis theory
for cancer which states that a tumor is able
to create its own blood supply. Dozens of
cancer drugs were developed based on his
research.
A.
B.
C.
D.

Dr J Michael Bishop
Dr Harold E Varmus
Dr Judah Folkman
Dr Brian J Druker
He hypothesised the angiogenesis theory
for cancer which states that a tumor is able
to create its own blood supply. Dozens of
cancer drugs were developed based on his
research.
A. Dr J Michael Bishop
B. Dr Harold E Varmus
Nobel for Oncogene 1989

C. Dr Judah Folkman
D. Dr Brian J Druker
Along with Nicholas B. Lydon and
Charles Sawyers, Lasker for CML

Contenu connexe

Tendances

Breast cancer ppt
Breast cancer pptBreast cancer ppt
Breast cancer ppt
drizsyed
 

Tendances (20)

Breast cancer screening
Breast cancer screeningBreast cancer screening
Breast cancer screening
 
Management of Early breast cancer
Management of Early breast cancer Management of Early breast cancer
Management of Early breast cancer
 
Breast cancer 2021
Breast cancer 2021Breast cancer 2021
Breast cancer 2021
 
The Latest Treatments for HER2-Positive Breast Cancer
The Latest Treatments for HER2-Positive Breast CancerThe Latest Treatments for HER2-Positive Breast Cancer
The Latest Treatments for HER2-Positive Breast Cancer
 
Prophylactic cranial irradiation
Prophylactic cranial irradiationProphylactic cranial irradiation
Prophylactic cranial irradiation
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Management of breast cancer
Management of breast cancerManagement of breast cancer
Management of breast cancer
 
RAPIDO TRIAL RECTUM
RAPIDO TRIAL RECTUMRAPIDO TRIAL RECTUM
RAPIDO TRIAL RECTUM
 
The Changing Role of PARP Inhibitors in the Treatment of Ovarian Cancer
The Changing Role of PARP Inhibitors in the Treatment of Ovarian CancerThe Changing Role of PARP Inhibitors in the Treatment of Ovarian Cancer
The Changing Role of PARP Inhibitors in the Treatment of Ovarian Cancer
 
Management of endometrial carcinoma
Management of endometrial carcinomaManagement of endometrial carcinoma
Management of endometrial carcinoma
 
Portec trial ppt
Portec trial pptPortec trial ppt
Portec trial ppt
 
Adjuvant systemic therapy in resectable non-small cell lung cancer, Moh'd sha...
Adjuvant systemic therapy in resectable non-small cell lung cancer, Moh'd sha...Adjuvant systemic therapy in resectable non-small cell lung cancer, Moh'd sha...
Adjuvant systemic therapy in resectable non-small cell lung cancer, Moh'd sha...
 
Breast cancer ppt
Breast cancer pptBreast cancer ppt
Breast cancer ppt
 
Cancer Screening
Cancer ScreeningCancer Screening
Cancer Screening
 
Treatment of breast cancer
Treatment of breast cancerTreatment of breast cancer
Treatment of breast cancer
 
Breast and cervical cancer awareness
Breast and cervical cancer awarenessBreast and cervical cancer awareness
Breast and cervical cancer awareness
 
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018
 
Prostate cancer updates 2021
Prostate cancer updates 2021Prostate cancer updates 2021
Prostate cancer updates 2021
 
Breast cancer screening
Breast cancer screeningBreast cancer screening
Breast cancer screening
 
Principles of Medical Oncology
Principles of Medical OncologyPrinciples of Medical Oncology
Principles of Medical Oncology
 

En vedette

Cv Slideshare
Cv SlideshareCv Slideshare
Cv Slideshare
Zinspelen
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th sept
Lifecare Centre
 
Top 52 clinical nurse specialist interview questions and answers pdf
Top 52 clinical nurse specialist interview questions and answers pdfTop 52 clinical nurse specialist interview questions and answers pdf
Top 52 clinical nurse specialist interview questions and answers pdf
kingmin609
 

En vedette (20)

Quiz in cancer
Quiz in cancerQuiz in cancer
Quiz in cancer
 
Quiz
QuizQuiz
Quiz
 
Chemo mcq's
Chemo mcq'sChemo mcq's
Chemo mcq's
 
Quiz
QuizQuiz
Quiz
 
111 questions &amp; answers about cervical cancer prevent
111 questions &amp; answers about cervical cancer prevent111 questions &amp; answers about cervical cancer prevent
111 questions &amp; answers about cervical cancer prevent
 
Cv Slideshare
Cv SlideshareCv Slideshare
Cv Slideshare
 
Template For Poster Presentation (Tysa)
Template For Poster Presentation (Tysa)Template For Poster Presentation (Tysa)
Template For Poster Presentation (Tysa)
 
Radiotherapy and Skin reaction
Radiotherapy and Skin reaction Radiotherapy and Skin reaction
Radiotherapy and Skin reaction
 
CASE STUDY ON CLINICAL NEUROANATOMY
CASE STUDY ON CLINICAL NEUROANATOMYCASE STUDY ON CLINICAL NEUROANATOMY
CASE STUDY ON CLINICAL NEUROANATOMY
 
Burns, wounds & pressure sores
Burns, wounds & pressure soresBurns, wounds & pressure sores
Burns, wounds & pressure sores
 
Internal Medicine Board Review - Oncology Flashcards - by Knowmedge
Internal Medicine Board Review - Oncology Flashcards -  by KnowmedgeInternal Medicine Board Review - Oncology Flashcards -  by Knowmedge
Internal Medicine Board Review - Oncology Flashcards - by Knowmedge
 
Screening for cervical cancer
Screening for  cervical cancerScreening for  cervical cancer
Screening for cervical cancer
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th sept
 
Neoplasia Robbin's path
Neoplasia Robbin's pathNeoplasia Robbin's path
Neoplasia Robbin's path
 
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
 
Top 52 clinical nurse specialist interview questions and answers pdf
Top 52 clinical nurse specialist interview questions and answers pdfTop 52 clinical nurse specialist interview questions and answers pdf
Top 52 clinical nurse specialist interview questions and answers pdf
 
Cervical cancer ppt
Cervical cancer pptCervical cancer ppt
Cervical cancer ppt
 
MOTIVATION POWERPOINT
MOTIVATION POWERPOINTMOTIVATION POWERPOINT
MOTIVATION POWERPOINT
 
TEDx Manchester: AI & The Future of Work
TEDx Manchester: AI & The Future of WorkTEDx Manchester: AI & The Future of Work
TEDx Manchester: AI & The Future of Work
 
How to Become a Thought Leader in Your Niche
How to Become a Thought Leader in Your NicheHow to Become a Thought Leader in Your Niche
How to Become a Thought Leader in Your Niche
 

Similaire à Oncology Quiz with answers

Grant Euroskin UV cancer prevention
Grant Euroskin UV cancer preventionGrant Euroskin UV cancer prevention
Grant Euroskin UV cancer prevention
lbmedien
 
White Paper- A non-invasive blood test for diagnosing lung cancer
White Paper- A non-invasive blood test for diagnosing lung cancerWhite Paper- A non-invasive blood test for diagnosing lung cancer
White Paper- A non-invasive blood test for diagnosing lung cancer
Dusty Majumdar, PhD
 
2016-Crawford-BMC Pulm Med published
2016-Crawford-BMC Pulm Med published2016-Crawford-BMC Pulm Med published
2016-Crawford-BMC Pulm Med published
Ji-Youn Yeo
 
Update on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.pptUpdate on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.ppt
SyedaAyeshaFatima2
 
Breast cancer oncotype-dx.. by dr.Kamel Farag, MD
Breast cancer oncotype-dx.. by dr.Kamel Farag, MDBreast cancer oncotype-dx.. by dr.Kamel Farag, MD
Breast cancer oncotype-dx.. by dr.Kamel Farag, MD
KamelFarag4
 

Similaire à Oncology Quiz with answers (20)

Previous year question on carcinma urinary bladder based on neet pg, usmle, p...
Previous year question on carcinma urinary bladder based on neet pg, usmle, p...Previous year question on carcinma urinary bladder based on neet pg, usmle, p...
Previous year question on carcinma urinary bladder based on neet pg, usmle, p...
 
Hstoria del tratamiento de cáncer del pulmón
Hstoria del tratamiento de cáncer del pulmónHstoria del tratamiento de cáncer del pulmón
Hstoria del tratamiento de cáncer del pulmón
 
Grant Euroskin Presentation
Grant Euroskin PresentationGrant Euroskin Presentation
Grant Euroskin Presentation
 
Grant Euroskin UV cancer prevention
Grant Euroskin UV cancer preventionGrant Euroskin UV cancer prevention
Grant Euroskin UV cancer prevention
 
Chapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancerChapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancer
 
White Paper- A non-invasive blood test for diagnosing lung cancer
White Paper- A non-invasive blood test for diagnosing lung cancerWhite Paper- A non-invasive blood test for diagnosing lung cancer
White Paper- A non-invasive blood test for diagnosing lung cancer
 
RESEARCH & TREATMENT NEWS: Highlights from the 2014 GI Cancer Symposium
RESEARCH & TREATMENT NEWS:  Highlights from the 2014 GI Cancer SymposiumRESEARCH & TREATMENT NEWS:  Highlights from the 2014 GI Cancer Symposium
RESEARCH & TREATMENT NEWS: Highlights from the 2014 GI Cancer Symposium
 
Overdiagnosis in cancer
Overdiagnosis in cancerOverdiagnosis in cancer
Overdiagnosis in cancer
 
cancer prevention.pptx
cancer prevention.pptxcancer prevention.pptx
cancer prevention.pptx
 
2016-Crawford-BMC Pulm Med published
2016-Crawford-BMC Pulm Med published2016-Crawford-BMC Pulm Med published
2016-Crawford-BMC Pulm Med published
 
Update on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.pptUpdate on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.ppt
 
Breast cancer oncotype-dx.. by dr.Kamel Farag, MD
Breast cancer oncotype-dx.. by dr.Kamel Farag, MDBreast cancer oncotype-dx.. by dr.Kamel Farag, MD
Breast cancer oncotype-dx.. by dr.Kamel Farag, MD
 
Human papillomavirus in head and neck cancer
Human papillomavirus in head and neck cancerHuman papillomavirus in head and neck cancer
Human papillomavirus in head and neck cancer
 
Immunotherapy Efforts and Fight CRC Dec 13 2017 Webinar
Immunotherapy Efforts and Fight CRC Dec 13 2017 WebinarImmunotherapy Efforts and Fight CRC Dec 13 2017 Webinar
Immunotherapy Efforts and Fight CRC Dec 13 2017 Webinar
 
Latest presentation of hpv in head and neck
Latest presentation of hpv in head and neckLatest presentation of hpv in head and neck
Latest presentation of hpv in head and neck
 
Cancer screening
Cancer screeningCancer screening
Cancer screening
 
GI and Liver Malignancies
GI and Liver MalignanciesGI and Liver Malignancies
GI and Liver Malignancies
 
Adjuvant treatment in early and localy advanced breast cancer
Adjuvant treatment in early and localy advanced breast cancerAdjuvant treatment in early and localy advanced breast cancer
Adjuvant treatment in early and localy advanced breast cancer
 
Chemotherapy for lung cancer
Chemotherapy for lung cancerChemotherapy for lung cancer
Chemotherapy for lung cancer
 
Chemotherapy for lung cancer
Chemotherapy for lung cancerChemotherapy for lung cancer
Chemotherapy for lung cancer
 

Dernier

Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
ssuserdda66b
 

Dernier (20)

ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 

Oncology Quiz with answers

  • 1. IASO Quiz 2013 Instituted by Dr Panda and Dr K Gopinath
  • 3. Identify this cancer survivor Lance Armstrong
  • 4. Following the 2012 USPSTF recommendation against PSA screening in all men, which group saw a decrease in screening frequency by PCPs? A. Men between 40-49yrs B. Men above 79 yrs C. Patients with previous highest PSA <2.49ng/ml D. All the above
  • 5. Following the 2012 USPSTF recommendation against PSA screening in all men, which group saw a decrease in screening frequency by PCPs? A. Men between 40-49yrs B. Men above 79 yrs C. Patients with previous highest PSA <2.49ng/ml D. All the above Cohn JA, et al. Urol Oncol. 2013 Aug 1. [Epub ahead of print]
  • 6. PSA screening is likely to reduce mortality due to prostate cancer. However the conclusion is likely to be affected by A. B. C. D. Selection Bias Lead and length Bias Exposure and measurement issues All the above
  • 7. PSA screening is likely to reduce mortality due to prostate cancer. However the conclusion is likely to be affected by A. B. C. D. Selection Bias Lead and length Bias Exposure and measurement issues All the above
  • 8. Urethral Cancer which invades bladder neck, single inguinal node 3cm is staged A. B. C. D. T4N2M0 T4N1M0 T2N1M0 T3N2M0
  • 9. Urethral Cancer which invades bladder neck, single inguinal node 3cm is staged A. B. C. D. T4N2M0 T4N1M0 T2N1M0 T3N2M0
  • 10. Micromets play an important role in the natural progression of urothelial cancer. What percentage of organ confined node negative bladder cancers recur following cystectomy? A. B. C. D. 25% 5% 40% 60%
  • 11. Micromets play an important role in the natural progression of urothelial cancer. What percentage of organ confined node negative bladder cancers recur following cystectomy? A. B. C. D. 25% 5% 40% 60% Bladder cancer: Diagnosis Therapeutics and Management. Ed.Cheryl T Lee and David P Wood. 2010 page 89.
  • 12. BCG for superficial bladder cancer can be potentiated for additional benefit if combined with which of the following: A. B. C. D. Mitomycin C Interferon Epirubicin None of the above
  • 13. BCG for superficial bladder cancer can be potentiated for additional benefit if combined with which of the following: A. B. C. D. Mitomycin C Interferon Epirubicin None of the above Zhu S et al. BMC cancer 2013,Jul 5; 13: 322. Pooled results of a recent meta-analysis of 21 RCT and 9 comparative studiess showed a better recurrence free survival for BCG+Epirubicin at the cost of an increase in toxicity.
  • 14. Intravesical BCG for non muscle invasive bladder cancer for older patients A. B. C. D. Improves Overall Survival Improves Bladder cancer specific survival Improves Os but not BCSS Improves OS and BCSS
  • 15. Intravesical BCG for non muscle invasive bladder cancer for older patients A. B. C. D. Improves Overall Survival Improves Bladder cancer specific survival Improves Os but not BCSS Improves OS and BCSS Spencer BA, et al. J Oncol Pract. 2013;9(2):92-98.
  • 16. Name the medicinal Plant/tree/seeds Supposed to enhance memory
  • 17. Name the medicinal Plant/tree/seeds Supposed to enhance memory Ginko biloba
  • 18. The correct statement below is: A. HPV vaccination is highly effective against development of cervical dysplasia B. HPV vaccination is highly effective against development of anal and cervical dysplasia C. HPV vaccination is highly effective against development of cervical, anal and oral dysplasia
  • 19. The correct statement below is: A. HPV vaccination is highly effective against development of cervical dysplasia B. HPV vaccination is highly effective against development of anal and cervical dysplasia C. HPV vaccination is highly effective against development of cervical, anal and oral dysplasia Palefsky et al. NEJM 2011;365(17):1576
  • 20. Vit D receptor Bsm1 polymorphism may represent a risk factor for _______ women with ovarian cancer A. B. C. D. Asian North American European South American
  • 21. Vit D receptor Bsm1 polymorphism may represent a risk factor for _______ women with ovarian cancer A. B. C. D. Asian North American European South American VDR Bsm1 polymorphism is generally no associated with Ovarian cancer risk. However a subgroup analysis of the study by Qin X et al ( Int J Gyn Cancer 2013. 23(7): 1178-83) showed european population to be at risk.
  • 22. Which is not a paraneoplastic syndrome associated with Lung Cancer A. B. C. D. Horner’ syndrome Lambert-Eaton Syndrome Sweet’s Syndrome Dermatomyositis
  • 23. Which is not a paraneoplastic syndrome associated with Lung Cancer A. B. C. D. Horner’ syndrome Lambert-Eaton Syndrome Sweet’s Syndrome Dermatomyositis The syndrome was first described in 1964 by Dr. Robert D Sweet. It was also known as Gomm-Button disease in honour of the first two patients diagnosed. It is characterized by erythematous well defined cutaneous papules associates with fever and is associated with haematologic malignancies like leukaemia, Rheumatoid Arthritis, IBD, Behcets Syndrome.
  • 24. The dividing line to discriminate 2R and 4R from 2L and 4L when staging Lung Cancer is A. Midline of trachea B. Right Border of Trachea C. Left border of Trachea
  • 25. The dividing line to discriminate 2R and 4R from 2L and 4L when staging Lung Cancer is A. Midline of trachea B. Right Border of Trachea C. Left border of Trachea
  • 26. Nodal station not amenable to be assessed by standard cervical mediastinoscopy for staging lung cancer A. B. C. D. Station 3 Station 6 Station 7 Station 5
  • 27. Nodal station not amenable to be assessed by standard cervical mediastinoscopy for staging lung cancer A. B. C. D. Station 3 Station 6 Station 7 Station 5
  • 28. This 62 yr old pathologist who has undergone complete resection for a lung cancer is staged pT2 N0 M0. He asks you regarding adjuvant therapy with Geftinib. Your answer is-A. Yes it is beneficial in stage Ib, II and IIIa lung cancer B. Adjuvant Geftinib benefits only wild type EGFR C. Adjuvant Geftinib benefits only mutant EGFR D. No benefit of Adjuvant Geftinib
  • 29. This 62 yr old pathologist who has undergone complete resection for a lung cancer is staged pT2 N0 M0. He asks you regarding adjuvant therapy with Geftinib. Your answer is-A. Yes it is beneficial in stage Ib, II and IIIa lung cancer B. Adjuvant Geftinib benefits only wild type EGFR C. Adjuvant Geftinib benefits only mutant EGFR D. No benefit of Adjuvant Geftinib Gross GD et al. JCO 2013; 31(17) 3320-26. Trial was stopped mid way due to lack of benefit
  • 30. Not associated with pleural Mesothelioma A. B. C. D. SV 40 infection Erionite exposure Thorium Dioxide therapy HPV Infection
  • 31. Not associated with pleural Mesothelioma A. B. C. D. SV 40 infection Erionite exposure Thorium Dioxide therapy HPV Infection Lung Cancer : Prevention, Management and Emerging Therapies. David J Stewart Ed. 2010; page 437.
  • 32. OCP and HRT use are associated with increase in breast cancer and Lung cancer A. True B. False
  • 33. OCP and HRT use are associated with increase in breast cancer and Lung cancer A. True B. False ILCC pooled analysis of 6 case control studies ( 1961 cases and 2609 controls) found a reduced risk of lung ca in HRT (Adeno and Small Cell) and OCP (Squamous CA)users. There was no dose response relationship with years of OCP/HRT. Pesatori AC et al. Br J Cancer 2013; 109(7) 1954-64.
  • 34. Which of the following is an inhibitor of PDGFR A. B. C. D. Dasatinib Vandetanib Sorafenib Imatinib
  • 35. Which of the following is an inhibitor of PDGFR A. B. C. D. Dasatinib Vandetanib Sorafenib Imatinib - VEGFR-2 DS DNA break repair Bcl-2
  • 36. Name the book by this Ethiopia born physician which talks of liver transplantation A. My Journey B. Another life C. Cutting for Stone D.Emperor’s Malady
  • 37. Name the book by this Ethiopia born physician which talks of liver transplantation A. My Journey B. Another life C. Cutting for Stone D.Emperor’s Malady
  • 38. Does higher UV radiation exposure of pregnant women reduce incidence of some childhood cancers A. Yes B. No
  • 39. Does higher UV radiation exposure of pregnant women reduce incidence of some childhood cancers A. Yes • • B. No Lombardi C et al. cancer Epidemiology, Biomarkers and Prevention 2013;22(6): 1118-1128 Results: For cases with UVR exposure of 5,111 Watt-hours/m2 or above, we estimated a reduction in odds of developing acute lymphoblastic leukemia (OR: 0.89, 95% CI: 0.81–0.99), hepatoblastoma (OR: 0.69, 95% CI: 0.48–1.00), and non-Hodgkin's lymphoma (OR: 0.71, 95% CI: 0.50–1.02) adjusting for mother's age, mother's race, and child's year of birth. We also observed a small increase in odds for intracranial/intraspinal embryonal tumors (OR: 1.29, 95% CI: 1.01–1.65). Conclusions: Our findings suggest that UVR during pregnancy may decrease the odds of some childhood cancers. Future studies should explore additional factors that may be correlated with UVR exposure and possibly include biomarkers of immune function and vitamin D.
  • 40. Melanoma subtype which is characterized by bland fibroblastic appearance and often mimics a scarA. B. C. D. Desmoplastic Acral Letigenous Nodular Lentigo maligna
  • 41. Melanoma subtype which is characterized by bland fibroblastic appearance and often mimics a scarA. B. C. D. Desmoplastic Acral Letigenous Nodular Lentigo maligna DM are strongly and homogeneously positive for S-100 protein but are often negative or only focally positive for melanocyte differentiation antigens such as tyrosinase, gp100, Melan-A, and microphthalmia transcription factor. DM differs from conventional melanoma in its clinical course. It is associated with a higher tendency for local recurrence, but metastases to regional lymph nodes are less common. Wood BA. Pathology 2013; 45(5): 453-463
  • 42. Who is this medical inventor A. Dr Eric Blom. B. Dr Robert Esther C. Dr Douglas J. Schwartzentruber
  • 43. Who is this medical inventor A. Dr Eric Blom. Inventor of the Blom Singer Prosthesis for laryngectomee patients B. Dr Robert Esther C. Dr Douglas J. Schwartzentruber Melanoma Vaccine
  • 44. Pet scan is often advised for follow-up in patients treated for HNSCC. Which of the following is correct statement A. PET scan does not obviate the need for standard radiology B. Two negative PET scans at 6 month intervals obviates the need for additional radiology C. Single negative PET scan obviates the need for additional radiology
  • 45. Pet scan is often advised for follow-up in patients treated for HNSCC. Which of the following is correct statement A. PET scan does not obviate the need for standard radiology B. Two negative PET scans at 6 month intervals obviates the need for additional radiology C. Single negative PET scan obviates the need for additional radiology Mc Dermott et al. AJNR 2013; 34(8): 1631-36 The NPV of 2 negative PET scans at 6 month intervals was 98% compared to 91% for a single negative PET scan
  • 46. Most likely site of an asymptomatic recurrence of H&N cancer is A. B. C. D. Thoracic Abdominal Regional nodal Primary site
  • 47. Most likely site of an asymptomatic recurrence of H&N cancer is A. B. C. D. Thoracic Abdominal Regional nodal Primary site Dunsky KA et al. Laryngoscope 2013; 123(9): 2161-64
  • 48. H&N Liposarcomas are likely to be A. Commonly deep and have poor outcome B. DFS and OS poorer than conventional liposarcoms C. Low grade and early stage D. Deep seated but low grade and stage
  • 49. H&N Liposarcomas are likely to be A. Commonly deep and have poor outcome B. DFS and OS poorer than conventional liposarcoms C. Low grade and early stage D. Deep seated but low grade and stage Gerry D et al. Head and Neck 2013; Jun 01 Epub
  • 50. Stage IVa H&N Melanoma is A. B. C. D. T1 N2 M0 T3 N1 M0 T4b N0 M0 T3 N2 M0
  • 51. Stage IVa H&N Melanoma is A. B. C. D. T1 N2 M0 T3 N1 M0 T4b N0 M0 T3 N2 M0
  • 52. One of the following is not implicated in the development of carcinoma of the larynx. A. B. C. D. Tobacco Leather Dust Strong Inorganic Mists Asbestos Dust and Fibre .
  • 53. One of the following is not implicated in the development of carcinoma of the larynx. A. B. C. D. Tobacco Leather Dust Strong Inorganic Mists Asbestos Dust and Fibre Head and Neck CA. Current Perspectives and Challenges. Ed James A Radosevich. 2013: page 58. The other 3 have a strong association. Others with limited evidence are HPV 16,18, Sulfur Mustard, Rubber production, secondary tobacco smoke. Less than 1% are due to alcohol alone.
  • 54. The journey of this physician’s discovery and clinical application was captured in a Hollywood movie in 2008 starring Harry Connick A. Living Proof B. A Gift of Life C. Nude Rats D.The Lonely Road
  • 55. The journey of this physician’s discovery and clinical application was captured in a Hollywood movie in 2008 starring Harry Connick A. Living Proof B. A Gift of Life C. Nude Rats D.The Lonely Road
  • 56. Triple negative breast cancers typically demonstrate A. B. C. D. Chemotherapy sensitivity Chemotherapy insensitivity Sensitive to only cisplatin Chemotherapy sensitivity followed shorter durable response
  • 57. Triple negative breast cancers typically demonstrate A. B. C. D. Chemotherapy sensitivity Chemotherapy insensitivity Sensitive to only cisplatin Chemotherapy sensitivity followed shorter durable response
  • 58. The residual tumour excised at surgery following neoadjuvant therapy with Trastuzumab and Chemotherapy is likely to have -A. B. C. D. Retained Her2 expression Gained Her2 point mutations Lost Her2 expression Lost Her2 point mutations
  • 59. The residual tumour excised at surgery following neoadjuvant therapy with Trastuzumab and Chemotherapy is likely to have -A. B. C. D. • Retained Her2 expression Gained Her2 point mutations Lost Her2 expression Lost Her2 point mutations In a study of 167 HER2-positive breast cancer patients, participants who received neoadjuvant chemotherapy without anti-HER2 treatment were more likely to demonstrate HER2 loss within their residual disease (40% vs 14.7%, P=0.019). Additionally, HER2 loss demonstrated a trend towards higher risk of relapse (HR 2.41, P=0.063). The pCR is confirmed as a powerful predictor of long-term outcome. The rate of HER2 loss is higher in patients receiving neoadjuvant CT without anti-HER2 agents. HER2 status on residual disease after preoperative therapy can be helpful in selecting patients at different risk of relapse, to be included in prospective trial exploring further adjuvant therapy. Guarneri V, et al. Ann Oncol. 2013 Sep 7. [Epub ahead of print]
  • 60. Which of the following predicts the possibility of recurrence in node negative breast cancer A. B. C. D. Lymphovascular invasion Age of patient Perineural spread Adjuvant radiotherapy
  • 61. Which of the following predicts the possibility of recurrence in node negative breast cancer A. B. C. D. Lymphovascular invasion Age of patient Perineural spread Adjuvant radiotherapy In a study of 716 patients with node-negative breast cancer, 47 ultimately recurred during 47 months of median follow-up. Lymphovascular invasion (HR 4.6) and Nottingham grade 3 (HR 4.99) tumors were independent risk factors associated with an increased risk of recurrence. Adjuvant radiotherapy (HR 0.35) decreased tumor recurrence, while adjuvant chemotherapy had no effect. Lin PH. J Surg Oncol 2013; 108(6): 352
  • 62. Your 52 yr old patient treated for HR+ EBC and now on Exemestrane says she is in the pink of health with no musculoskeletal symptoms, vasomotor or vulvovaginal symptoms. Inference on her survival-A. She likely to have a decreased survival B. No inference can be drawn C. She has same survival as for her stage of cancer D. She is likely to have a better survival
  • 63. Your 52 yr old patient treated for HR+ EBC and now on Exemestrane says she is in the pink of health with no musculoskeletal symptoms, vasomotor or vulvovaginal symptoms. Inference on her survival-A. B. C. D. She likely to have a decreased survival No inference can be drawn She has same survival as for her stage of cancer She is likely to have a better survival Fontein DB et al. JCO 2013; 31(18): 2257-64 International Tamoxifen Exemestrane Multinational Trial
  • 64. The drugs recommended for breast cancer risk reduction in a 50yr old postmenopausal lady with family history of breast cancer and dense breasts are A. Raloxifene or Tamoxifen B. Raloxifene only C. Raloxifene, Tamoxifen and Exemestrane
  • 65. The drugs recommended for breast cancer risk reduction in a 50yr old postmenopausal lady with family history of breast cancer and dense breasts are A. Raloxifene or Tamoxifen B. Raloxifene only C. Raloxifene, Tamoxifen and Exemestrane Moyer VA, et al. Ann Intern Med. 2013 Sep 24. USPSTF recommendations
  • 66. Attachment of H Pylori to the gastric epithelium leads to activation of NF-Kb and increased A. IL-8 B. VEGF C. MMP-2 D. HGF
  • 67. Attachment of H Pylori to the gastric epithelium leads to activation of NF-Kb and increased A. IL-8 B. VEGF C. MMP-2 D. HGF
  • 68. Use of S-1 a novel drug based on 5FU with Cisplatin compared to the standard Cisplatin + 5FU for gastric cancer reveals A. Cis plat + S-1 is more effective B. Increased incidence of Stomatitis, Febrile neutropenia C. Lower incidence of hand foot syndrome D. Increased treatment related deaths
  • 69. Use of S-1 a novel drug based on 5FU with Cisplatin compared to the standard Cisplatin + 5FU for gastric cancer reveals A. Cis plat + S-1 is more effective B. Increased incidence of Stomatitis, Febrile neutropenia C. Lower incidence of hand foot syndrome D. Increased treatment related deaths Ajani JA et al. Eur J Cancer 2013; 49(17):3616-24. CS is noninferior to CF and has improved safety
  • 70. What is not true for follow up of Stage II and III Colon Cancer A. 80% recurrences occur in the first 2-2.5 yrs B. CT abdomen and chest recommended annually for 3 yrs C. If surveillance colonoscopy is fine at 1 yr colonoscopy is done every 2 yrs D. PET scan can be recommended as part of a trial only
  • 71. What is not true for follow up of Stage II and III Colon Cancer A. 80% recurrences occur in the first 2-2.5 yrs B. CT abdomen and chest recommended annually for 3 yrs C. If surveillance colonoscopy is fine at 1 yr colonoscopy is done every 2 yrs D. PET scan can be recommended as part of a trial only ASCO endorsed the guideline prepared by CCO ( JCO Nov 2012 )
  • 72. Incorrect about carcinoid tumours A. Causes depletion of tyrosine B. Some patients may have dermatological manifestations in sun exposed parts C. 10% secrete excessive levels of Serotonin D. May produce tricuspid stenosis
  • 73. Incorrect about carcinoid tumours A. Causes depletion of tyrosine. The aminoacid depleted is tryptophan B. Some patients may have dermatological manifestations in sun exposed parts C. 10% secrete excessive levels of Serotonin D. May produce tricuspid stenosis
  • 74. This computer scientist and professor at Carnagie Mellon University was an author of a best seller called A. Alice project B. Time management C. Achieving your childhood dreams D.The last lecture
  • 75. This computer scientist and professor at Carnagie Mellon University was an author of a best seller called A. Alice project B. Time management C. Achieving your childhood dreams D.The last lecture by Randy Pausch
  • 76. The 5 year survival of stage 1 pancreatic cancer is-A. B. C. D. Less than 30% 50% 65% 5%
  • 77. The 5 year survival of stage 1 pancreatic cancer is-A. B. C. D. Less than 30% 50% 65% 5%
  • 78. In patients with nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs), when preoperative grading assessment is not achieved, which clinical variable is an excellent predictor of post-treatment nodal positivity? A. B. C. D. Radiological tumour size BMI Age Gender
  • 79. In patients with nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs), when preoperative grading assessment is not achieved, which clinical variable is an excellent predictor of post-treatment nodal positivity? A. B. C. D. Radiological tumour size BMI Age Gender Partelli S, et al. JAMA Surg. 2013;148(10):932-939.
  • 80. In patients with hepatocellular carcinoma (HCC) receiving transarterial therapy (TACE/TAE), which is NOT a prognostic factor for risk of death? A. B. C. D. Albumin > 3.6 g/dl Bilirubin > 17umol/l Tumour Size > 7 cm AFP >400ng/dl
  • 81. In patients with hepatocellular carcinoma (HCC) receiving transarterial therapy (TACE/TAE), which is NOT a prognostic factor for risk of death? A. B. C. D. Albumin > 3.6 g/dl Bilirubin > 17umol/l Tumour Size > 7 cm AFP >400ng/dl This is the hepatoma arterial embolization prognostic score. Kadalayil L, et al. Ann Oncol. 2013;24(10):2565-2570.
  • 82. For adult survivors of childhood cancer, which organ system is the most at-risk for disease during adulthood after exposure to treatment with potential toxicity? A. B. C. D. Pulmonary Haematopoietic Hepatic Gastrointestinal .
  • 83. For adult survivors of childhood cancer, which organ system is the most at-risk for disease during adulthood after exposure to treatment with potential toxicity? A. B. C. D. Pulmonary Haematopoietic Hepatic Gastrointestinal Less than 15% develop haematopoietic, hepatic, skeletal dysfunction. Other organs at risk are cardiac, neurologic, neurocognitive and endocrine. Hudson MM, et al. JAMA. 2013;309(22):2371-2381.
  • 84. What percentage of adult survivors of childhood cancer develop an adult neoplasm (benign and or malignant) A. B. C. D. 16% 45% 3% 0.5%
  • 85. What percentage of adult survivors of childhood cancer develop an adult neoplasm (benign and or malignant) A. B. C. D. 16% 45% 3% 0.5% Hudson MM, et al. JAMA. 2013;309(22):2371-2381.
  • 86. This actor was diagnosed with ---- in the film A. Leukaemia B. Brain Tumour C. Lymphosarcoma of Intestine
  • 87. Risk of recurrence in GIST after surgery is high (55% or more)in all except: A. B. C. D. More than 10 cm size in any location 2-5cm with mitosis 5 per 50HPF Mucosal invasion Mitosis >1 per 5HPF
  • 88. Risk of recurrence in GIST after surgery is high (55% or more)in all except: A. B. C. D. More than 10 cm size in any location 2-5cm with mitosis 5 per 50HPF Mucosal invasion Mitosis >1 per 5HPF
  • 89. Most of the GIST are positive for CD117. Approximately 8% are CD117 negative but PDGFRA positive. These tumours areA. Clinically indolent, located in small intestine B. Clinically aggressive, located in stomach and C. Clinically indolent, located in stomach,
  • 90. Most of the GIST are positive for CD117. Approximately 8% are CD117 negative but PDGFRA positive. These tumours areA. Clinically indolent, located in small intestine B. Clinically aggressive, located in stomach and C. Clinically indolent, located in stomach Haematology Oncology Clinics: Rare Cancers. Dec 2012. These PDGFRA positive tumours commonly are of epithelioid morphology and the commonest mutation is on exon 18 (D842V) which makes them resistant to TKI
  • 91. The expected DFS following non operative management of clinical CR of Stage I-III rectal cancer treated by neoadjuvant CCRT is A. B. C. D. 50% 80% 60% 40%
  • 92. The expected DFS following non operative management of clinical CR of Stage I-III rectal cancer treated by neoadjuvant CCRT is A. B. C. D. 50% 80% 60% 40% Solanki AA et al. Onco Targets and therapy 2013; 2013(6): 1097-1110
  • 93. Who is this surgeon A.Frank H. Netter B.B Fisher C.CW Lilliehei
  • 94. Who is this surgeon A. Frank H. Netter was an American surgeon and celebrated medical illustrator. The first edition of his Atlas of Human Anatomy — his "personal Sistine Chapel" — was published in 1989 and he was made a Fellow of the New York Academy of Medicine B. B Fisher C. CW Lilliehei
  • 95. Statistics: the incorrect statement is A. Type 1 error is fixed apriori B. Increasing sample size has no effect on type 2 error C. Doubling sample size does not affect confidence interval D. Sample size and effect size are inversely related
  • 96. Statistics: the incorrect statement is A. Type 1 error is fixed apriori B. Increasing sample size has no effect on type 2 error C. Doubling sample size does not affect confidence interval D. Sample size and effect size are inversely related
  • 97. Which is not a subtypes of Chondroma A. B. C. D. Ectochondroma Enchondroma Perosteal chondroma Soft tissue Chondroma
  • 98. Which is not a subtypes of Chondroma A. B. C. D. Ectochondroma Enchondroma Perosteal chondroma Soft tissue Chondroma
  • 99. What minimum dose of radiation is needed to produce a statistically superior response to bone pain A. B. C. D. 10 Gy 8 Gy 15 Gy 4 Gy
  • 100. What minimum dose of radiation is needed to produce a statistically superior response to bone pain A. B. C. D. 10 Gy 8 Gy 15 Gy 4 Gy Dennis K. Radiother Oncol 2013; 106(1) 5-14 In this systematic analysis the authors found that the minimum dose of 8Gy was needed to reduce pain in bone mets.
  • 101. Most common Uterine Sarcoma A. B. C. D. Carcinosarcoma Endometrial stromal sarcoma Leiomyosarcoma Adenosarcoma
  • 102. Most common Uterine Sarcoma A. B. C. D. Carcinosarcoma Endometrial stromal sarcoma Leiomyosarcoma Adenosarcoma
  • 103. He hypothesised the angiogenesis theory for cancer which states that a tumor is able to create its own blood supply. Dozens of cancer drugs were developed based on his research. A. B. C. D. Dr J Michael Bishop Dr Harold E Varmus Dr Judah Folkman Dr Brian J Druker
  • 104. He hypothesised the angiogenesis theory for cancer which states that a tumor is able to create its own blood supply. Dozens of cancer drugs were developed based on his research. A. Dr J Michael Bishop B. Dr Harold E Varmus Nobel for Oncogene 1989 C. Dr Judah Folkman D. Dr Brian J Druker Along with Nicholas B. Lydon and Charles Sawyers, Lasker for CML